Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Nicole Gonzales

Concepts (307)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
108
4.540
 Why?
Stroke
39
2025
1120
3.590
 Why?
Neurology
5
2024
113
2.300
 Why?
Tissue Plasminogen Activator
23
2024
224
2.190
 Why?
Brain Ischemia
19
2025
338
1.810
 Why?
Fibrinolytic Agents
17
2024
270
1.630
 Why?
Thrombolytic Therapy
14
2024
142
1.500
 Why?
Sexism
1
2024
61
0.840
 Why?
Hematoma
6
2015
53
0.810
 Why?
Ischemic Attack, Transient
1
2023
65
0.790
 Why?
Endarterectomy, Carotid
4
2015
49
0.740
 Why?
Platelet Aggregation Inhibitors
3
2022
463
0.680
 Why?
Education, Medical
1
2024
266
0.680
 Why?
Carotid Stenosis
4
2014
91
0.670
 Why?
Women
1
2020
50
0.660
 Why?
Decompressive Craniectomy
1
2019
8
0.640
 Why?
Medicine
1
2020
121
0.600
 Why?
Time-to-Treatment
2
2021
205
0.600
 Why?
Matrix Metalloproteinases
1
2019
95
0.580
 Why?
Stents
5
2015
527
0.570
 Why?
Mobile Health Units
3
2024
21
0.540
 Why?
Percutaneous Coronary Intervention
1
2022
480
0.540
 Why?
Attention
1
2020
427
0.520
 Why?
Angioplasty
2
2014
47
0.520
 Why?
Brain Injuries
1
2020
494
0.460
 Why?
Cerebral Revascularization
1
2014
19
0.450
 Why?
Emergency Medical Services
5
2024
552
0.450
 Why?
Aged
39
2024
23961
0.440
 Why?
Humans
69
2025
137585
0.420
 Why?
Middle Aged
42
2025
33479
0.420
 Why?
Treatment Outcome
28
2023
10811
0.420
 Why?
Diffusion Tensor Imaging
2
2024
79
0.410
 Why?
Cerebral Ventricles
3
2024
52
0.400
 Why?
Thiazolidinediones
2
2012
137
0.370
 Why?
Hypertension
3
2016
1295
0.360
 Why?
Female
47
2025
73304
0.340
 Why?
Male
49
2025
67762
0.340
 Why?
Health Education
4
2023
341
0.330
 Why?
Disability Evaluation
3
2021
290
0.310
 Why?
Clinical Trials as Topic
6
2023
1050
0.300
 Why?
Prospective Studies
14
2024
7604
0.290
 Why?
Aged, 80 and over
19
2024
7635
0.280
 Why?
Time Factors
12
2025
6828
0.260
 Why?
Schools
2
2007
461
0.260
 Why?
Risk Factors
10
2025
10388
0.250
 Why?
Awareness
1
2007
103
0.250
 Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
3
0.240
 Why?
Paraneoplastic Syndromes, Nervous System
1
2005
12
0.240
 Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.240
 Why?
Anticoagulants
3
2019
664
0.230
 Why?
Cerebral Intraventricular Hemorrhage
1
2024
4
0.230
 Why?
Cerebral Blood Volume
1
2024
5
0.230
 Why?
Healthcare Disparities
2
2024
654
0.220
 Why?
American Heart Association
2
2023
306
0.210
 Why?
Skin Diseases, Vesiculobullous
1
2003
18
0.210
 Why?
Encephalitis, Herpes Simplex
1
2003
21
0.210
 Why?
Herpesvirus 2, Human
1
2003
29
0.210
 Why?
Pyramidal Tracts
1
2023
31
0.200
 Why?
Pilot Projects
5
2023
1710
0.200
 Why?
Antihypertensive Agents
3
2016
494
0.200
 Why?
Cytochrome P-450 CYP2C19
1
2022
25
0.200
 Why?
Hypoglycemic Agents
1
2012
1291
0.200
 Why?
Ambulances
2
2021
51
0.200
 Why?
Academic Medical Centers
2
2024
512
0.200
 Why?
Postoperative Complications
1
2014
2654
0.190
 Why?
Health Status Disparities
1
2025
289
0.190
 Why?
Adult
19
2025
37929
0.190
 Why?
Heterozygote
1
2022
293
0.190
 Why?
Databases, Factual
3
2019
1357
0.180
 Why?
Retrospective Studies
16
2025
15657
0.180
 Why?
PPAR gamma
3
2014
182
0.180
 Why?
Prognosis
6
2025
4030
0.180
 Why?
Health Promotion
2
2007
741
0.180
 Why?
Neuroprotective Agents
2
2015
131
0.180
 Why?
Faculty, Medical
1
2024
283
0.180
 Why?
Sex Factors
4
2025
2071
0.170
 Why?
Anxiety Disorders
1
2023
377
0.170
 Why?
United States
10
2024
14841
0.160
 Why?
Factor VIIa
2
2011
41
0.160
 Why?
Inpatients
1
2024
500
0.160
 Why?
Aspirin
1
2022
387
0.160
 Why?
Pipecolic Acids
2
2012
26
0.160
 Why?
Schools, Medical
1
2020
147
0.160
 Why?
Predictive Value of Tests
4
2019
2031
0.160
 Why?
Overweight
1
2023
558
0.150
 Why?
Recovery of Function
3
2019
653
0.150
 Why?
Edema
1
2019
130
0.140
 Why?
Glasgow Coma Scale
1
2019
186
0.140
 Why?
Health Services Needs and Demand
1
2020
273
0.140
 Why?
Isoenzymes
1
2019
304
0.140
 Why?
Adenocarcinoma
1
2005
940
0.140
 Why?
Communication
1
2024
879
0.140
 Why?
Dose-Response Relationship, Drug
4
2012
2057
0.140
 Why?
Propensity Score
1
2019
294
0.140
 Why?
Disease Progression
3
2013
2757
0.140
 Why?
NF-E2-Related Factor 2
2
2015
93
0.140
 Why?
Mexican Americans
2
2009
120
0.140
 Why?
Genotype
1
2022
1916
0.140
 Why?
Injury Severity Score
1
2019
522
0.130
 Why?
Hospital Mortality
2
2019
911
0.130
 Why?
Platelet Transfusion
1
2017
67
0.130
 Why?
Decision Making
1
2023
900
0.130
 Why?
Ultrasonography, Doppler, Transcranial
3
2013
45
0.130
 Why?
Anxiety
1
2023
1035
0.130
 Why?
Severity of Illness Index
8
2024
2828
0.130
 Why?
Tomography, X-Ray Computed
4
2021
2691
0.120
 Why?
Texas
4
2013
244
0.120
 Why?
Fumarates
1
2015
9
0.120
 Why?
Microglia
2
2008
251
0.120
 Why?
Quality of Health Care
1
2020
642
0.120
 Why?
Antithrombins
2
2013
60
0.120
 Why?
Pneumonia, Viral
1
2020
373
0.120
 Why?
Coronavirus Infections
1
2020
364
0.110
 Why?
Retinoid X Receptors
1
2014
39
0.110
 Why?
Anti-Inflammatory Agents
2
2011
496
0.110
 Why?
Recombinant Proteins
4
2011
1353
0.110
 Why?
Intraoperative Complications
1
2015
138
0.110
 Why?
Risk Assessment
2
2025
3457
0.110
 Why?
Blood Pressure
3
2011
1786
0.110
 Why?
Cerebral Infarction
1
2014
44
0.110
 Why?
Single-Blind Method
1
2014
282
0.110
 Why?
Neutrophil Infiltration
1
2014
107
0.110
 Why?
Registries
3
2025
2035
0.110
 Why?
Perioperative Care
1
2015
178
0.110
 Why?
Cohort Studies
7
2022
5742
0.100
 Why?
Follow-Up Studies
4
2017
5131
0.100
 Why?
Odds Ratio
3
2021
1070
0.100
 Why?
Quality Control
1
2013
172
0.100
 Why?
Delivery of Health Care
1
2020
951
0.100
 Why?
Sulfonamides
3
2012
513
0.100
 Why?
Genetic Predisposition to Disease
1
2021
2426
0.100
 Why?
Medical Records
1
2013
177
0.100
 Why?
Biomarkers
2
2019
4149
0.100
 Why?
Telemedicine
2
2020
862
0.090
 Why?
Lung Neoplasms
1
2005
2526
0.090
 Why?
Exercise
1
2023
2057
0.090
 Why?
Carotid Artery, Internal
1
2011
42
0.090
 Why?
Cyclooxygenase 2 Inhibitors
1
2011
21
0.090
 Why?
Celecoxib
1
2011
39
0.090
 Why?
Cerebral Amyloid Angiopathy
1
2011
10
0.090
 Why?
Collagen Type IV
1
2011
28
0.090
 Why?
Neurosurgical Procedures
1
2013
197
0.090
 Why?
Nervous System Diseases
1
2014
266
0.090
 Why?
Brain Edema
1
2011
61
0.090
 Why?
History, 20th Century
1
2012
325
0.090
 Why?
Carotid Arteries
1
2012
206
0.090
 Why?
NF-kappa B
1
2014
691
0.090
 Why?
Universities
1
2013
433
0.080
 Why?
Injections, Intra-Arterial
4
2013
27
0.080
 Why?
Nephrology
1
2011
61
0.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
24
0.080
 Why?
Double-Blind Method
2
2012
1993
0.080
 Why?
Treatment Failure
2
2014
356
0.080
 Why?
Heparin
1
2011
261
0.080
 Why?
Resuscitation Orders
1
2009
44
0.080
 Why?
Health Care Surveys
1
2011
565
0.080
 Why?
Endovascular Procedures
1
2013
312
0.080
 Why?
Hand Transplantation
1
2008
9
0.070
 Why?
Research Design
2
2013
1139
0.070
 Why?
Intracranial Thrombosis
1
2008
17
0.070
 Why?
Venous Thrombosis
1
2011
190
0.070
 Why?
Caffeine
1
2009
68
0.070
 Why?
Adolescent
8
2025
21513
0.070
 Why?
Hand Injuries
1
2008
31
0.070
 Why?
Neutrophils
1
2014
1238
0.070
 Why?
Embolism
1
2008
41
0.070
 Why?
Hypothermia, Induced
1
2009
80
0.070
 Why?
Pyrazoles
1
2011
423
0.070
 Why?
Quality Improvement
1
2016
1178
0.070
 Why?
Surveys and Questionnaires
1
2020
5778
0.070
 Why?
Practice Patterns, Physicians'
2
2017
1313
0.070
 Why?
Renal Dialysis
1
2011
435
0.070
 Why?
Nerve Fibers, Myelinated
1
2005
47
0.060
 Why?
Organ Transplantation
1
2008
250
0.060
 Why?
Teaching
1
2007
224
0.060
 Why?
Methylprednisolone
1
2005
86
0.060
 Why?
Kidney Failure, Chronic
1
2011
570
0.060
 Why?
Emergency Treatment
1
2006
118
0.060
 Why?
Heart Diseases
1
2008
346
0.060
 Why?
Brain Stem
1
2005
94
0.060
 Why?
Paralysis
1
2005
71
0.060
 Why?
Muscle Weakness
1
2005
88
0.060
 Why?
Young Adult
3
2025
13209
0.060
 Why?
Fatal Outcome
1
2005
303
0.060
 Why?
Injections, Intravenous
3
2011
206
0.060
 Why?
Program Development
1
2007
364
0.060
 Why?
Quality-Adjusted Life Years
1
2024
113
0.060
 Why?
Emergency Service, Hospital
1
2016
2069
0.060
 Why?
Administration, Intravenous
2
2017
155
0.060
 Why?
Ethanol
1
2009
608
0.050
 Why?
Phagocytosis
3
2014
380
0.050
 Why?
Case-Control Studies
3
2021
3556
0.050
 Why?
Diffusion Magnetic Resonance Imaging
1
2005
153
0.050
 Why?
Peptides
1
2009
985
0.050
 Why?
Chi-Square Distribution
2
2017
530
0.050
 Why?
Meningitis, Aseptic
1
2003
13
0.050
 Why?
Growth and Development
1
2023
7
0.050
 Why?
Hemorrhage
2
2023
722
0.050
 Why?
Principal Component Analysis
1
2023
195
0.050
 Why?
Spinal Cord
1
2005
370
0.050
 Why?
Headache
1
2003
147
0.050
 Why?
Brain
1
2014
2668
0.050
 Why?
Catalase
2
2014
130
0.050
 Why?
Students
1
2007
622
0.050
 Why?
Certification
1
2023
113
0.050
 Why?
Acute Disease
3
2011
1007
0.050
 Why?
Age Factors
2
2025
3295
0.050
 Why?
Cost-Benefit Analysis
1
2024
591
0.050
 Why?
Respiratory Insufficiency
1
2005
318
0.050
 Why?
Partial Thromboplastin Time
2
2012
57
0.050
 Why?
Reperfusion
2
2013
40
0.040
 Why?
DNA, Viral
1
2003
364
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
976
0.040
 Why?
Macrophages
1
2008
1547
0.040
 Why?
Practice Guidelines as Topic
3
2017
1587
0.040
 Why?
Hospital Bed Capacity
1
2020
26
0.040
 Why?
Guideline Adherence
2
2017
556
0.040
 Why?
Health Care Rationing
1
2020
59
0.040
 Why?
Caregivers
1
2007
877
0.040
 Why?
Ethics, Medical
1
2020
84
0.040
 Why?
Kaplan-Meier Estimate
2
2012
889
0.040
 Why?
Magnetic Resonance Imaging
3
2023
3566
0.040
 Why?
Health Resources
1
2020
120
0.040
 Why?
Rats, Sprague-Dawley
2
2015
2486
0.040
 Why?
Logistic Models
2
2017
2074
0.040
 Why?
Incidence
1
2025
2804
0.040
 Why?
Combined Modality Therapy
2
2013
1236
0.040
 Why?
CD36 Antigens
2
2008
36
0.040
 Why?
Hospitals
1
2023
691
0.040
 Why?
Arginine
2
2012
271
0.030
 Why?
Ventriculostomy
1
2017
21
0.030
 Why?
Autoantibodies
1
2005
1496
0.030
 Why?
Betacoronavirus
1
2020
270
0.030
 Why?
Statistics, Nonparametric
1
2017
431
0.030
 Why?
Drug Therapy, Combination
2
2012
1066
0.030
 Why?
Rats
2
2015
5647
0.030
 Why?
Longitudinal Studies
1
2023
2844
0.030
 Why?
Disease Models, Animal
3
2014
4295
0.030
 Why?
Dimethyl Fumarate
1
2015
12
0.030
 Why?
Thrombocytopenia
1
2017
200
0.030
 Why?
Body Mass Index
1
2023
2389
0.030
 Why?
Neuroimmunomodulation
1
2014
65
0.030
 Why?
Intensive Care Units
1
2020
827
0.030
 Why?
Perfusion Imaging
1
2014
58
0.030
 Why?
Biomedical Research
1
2020
692
0.030
 Why?
Multivariate Analysis
1
2017
1509
0.030
 Why?
Animals
5
2015
36940
0.030
 Why?
Sex Distribution
1
2014
375
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2012
20
0.020
 Why?
Health Services Accessibility
1
2020
986
0.020
 Why?
Erythrocytes
2
2008
700
0.020
 Why?
Cerebral Veins
1
2012
16
0.020
 Why?
Cerebral Arteries
1
2012
59
0.020
 Why?
Pandemics
1
2020
1639
0.020
 Why?
Plasminogen Activators
1
2011
7
0.020
 Why?
Quality of Life
1
2023
2892
0.020
 Why?
Heparin, Low-Molecular-Weight
1
2011
34
0.020
 Why?
Radiography
1
2013
822
0.020
 Why?
Mice, Inbred C57BL
2
2015
5757
0.020
 Why?
Magnetic Resonance Angiography
1
2012
240
0.020
 Why?
Analysis of Variance
1
2013
1316
0.020
 Why?
Obesity
1
2023
2992
0.020
 Why?
Length of Stay
1
2015
1215
0.020
 Why?
Life Support Care
1
2009
33
0.020
 Why?
Buspirone
1
2009
3
0.020
 Why?
Meperidine
1
2009
3
0.020
 Why?
Shivering
1
2009
5
0.020
 Why?
Adjuvants, Anesthesia
1
2009
12
0.020
 Why?
Mice
3
2015
17787
0.020
 Why?
Microcirculation
1
2009
149
0.020
 Why?
Microspheres
1
2009
137
0.020
 Why?
Brain Damage, Chronic
1
2008
18
0.020
 Why?
Anti-Anxiety Agents
1
2009
46
0.020
 Why?
Infusions, Intra-Arterial
1
2008
59
0.020
 Why?
Cerebral Angiography
1
2008
109
0.020
 Why?
Mice, Knockout
1
2015
3015
0.020
 Why?
Drug Combinations
1
2009
343
0.020
 Why?
Blood Flow Velocity
1
2009
413
0.020
 Why?
Behavior
1
2008
90
0.020
 Why?
Infusions, Intravenous
1
2008
413
0.020
 Why?
Enzyme Activators
1
2007
9
0.020
 Why?
Cultural Competency
1
2008
85
0.020
 Why?
Prostaglandin D2
1
2007
23
0.020
 Why?
Regression Analysis
1
2009
1024
0.020
 Why?
Deep Brain Stimulation
1
2009
153
0.020
 Why?
Urokinase-Type Plasminogen Activator
1
2006
29
0.020
 Why?
Nitric Oxide Synthase Type II
1
2007
173
0.020
 Why?
Graft Survival
1
2008
535
0.020
 Why?
Hydrogen Peroxide
1
2007
328
0.010
 Why?
Reproducibility of Results
1
2013
3284
0.010
 Why?
Recurrence
1
2008
1060
0.010
 Why?
Urban Population
1
2008
479
0.010
 Why?
Animals, Newborn
1
2007
844
0.010
 Why?
Graft Rejection
1
2008
624
0.010
 Why?
Self Efficacy
1
2008
396
0.010
 Why?
Recombinant Fusion Proteins
1
2006
665
0.010
 Why?
Atrial Fibrillation
1
2008
388
0.010
 Why?
Myocardial Infarction
1
2011
1046
0.010
 Why?
Program Evaluation
1
2007
898
0.010
 Why?
Curriculum
1
2007
992
0.010
 Why?
Apoptosis
1
2008
2553
0.010
 Why?
Cells, Cultured
1
2007
4193
0.010
 Why?
Cytokines
1
2007
2085
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2007
1329
0.010
 Why?
Parents
1
2007
1347
0.010
 Why?
Neurons
1
2007
1590
0.010
 Why?
Child
1
2007
21935
0.000
 Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (307) concept(s)
_
Co-Authors Expand Description
See all (12) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)